Vertex Pharmaceuticals has announced that the European Commission has granted approval to extend the indication of the drug Kaftrio (ivacaftor / tezacaftor / elexacaftor) in combination with ivacaftor for the treatment of children with Cystic Fibrosis aged 2-5 years with at least one copy of the F508del mutation in the CFTR gene, regardless of their […]
Uncategorized
The Respiralia Group supports the ERS Tobacco 21 Campaign
The Respiralia Group supports the Tobacco 21 campaign launched by the European Respiratory Society through the European Union. Lung Cancer Awareness Month In this Lung Cancer Awareness Month, the ERS encourages its members to support the “Tobacco 21” campaign and help Europe move towards the end of smoking. The Respiralia Group develops the program “PrevAction: […]
Solidarity music in favor of the Respiralia Foundation
The Agrupació vocal “Tot Cor” helps the fight against Cystic Fibrosis with its solidarity music in favor of the Respiralia Foundation, with a donation of 180,00 €. Young people in love of solidarity music The members of this musical group are people who have been in different choirs in previous years and have decided to […]
